1. Home
  2. XCUR vs RDI Comparison

XCUR vs RDI Comparison

Compare XCUR & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XCUR
  • RDI
  • Stock Information
  • Founded
  • XCUR 2011
  • RDI 1937
  • Country
  • XCUR United States
  • RDI United States
  • Employees
  • XCUR N/A
  • RDI N/A
  • Industry
  • XCUR Biotechnology: Pharmaceutical Preparations
  • RDI Movies/Entertainment
  • Sector
  • XCUR Health Care
  • RDI Consumer Discretionary
  • Exchange
  • XCUR Nasdaq
  • RDI Nasdaq
  • Market Cap
  • XCUR 29.4M
  • RDI 31.3M
  • IPO Year
  • XCUR N/A
  • RDI N/A
  • Fundamental
  • Price
  • XCUR $4.44
  • RDI $1.40
  • Analyst Decision
  • XCUR
  • RDI
  • Analyst Count
  • XCUR 0
  • RDI 0
  • Target Price
  • XCUR N/A
  • RDI N/A
  • AVG Volume (30 Days)
  • XCUR 39.7K
  • RDI 24.3K
  • Earning Date
  • XCUR 11-10-2025
  • RDI 11-12-2025
  • Dividend Yield
  • XCUR N/A
  • RDI N/A
  • EPS Growth
  • XCUR N/A
  • RDI N/A
  • EPS
  • XCUR N/A
  • RDI N/A
  • Revenue
  • XCUR N/A
  • RDI $219,213,000.00
  • Revenue This Year
  • XCUR N/A
  • RDI $6.85
  • Revenue Next Year
  • XCUR N/A
  • RDI $10.86
  • P/E Ratio
  • XCUR N/A
  • RDI N/A
  • Revenue Growth
  • XCUR N/A
  • RDI 7.59
  • 52 Week Low
  • XCUR $2.44
  • RDI $1.17
  • 52 Week High
  • XCUR $36.00
  • RDI $1.87
  • Technical
  • Relative Strength Index (RSI)
  • XCUR 45.66
  • RDI 44.35
  • Support Level
  • XCUR $4.37
  • RDI $1.41
  • Resistance Level
  • XCUR $5.26
  • RDI $1.51
  • Average True Range (ATR)
  • XCUR 0.39
  • RDI 0.06
  • MACD
  • XCUR -0.02
  • RDI -0.00
  • Stochastic Oscillator
  • XCUR 5.88
  • RDI 31.25

About XCUR Exicure Inc.

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

Share on Social Networks: